Expert-Grade Biomedical Compliance Insights for Medical Device Teams

This AI Transformation analyzes Design History Files, Design and Development Files, design control records, risk files, V&V records, traceability matrices, transfer records, and change-control documentation for medical device and biomedical product teams. It converts complex design control evidence into structured audit-readiness intelligence, surfacing signals such as missing DHF evidence, weak input-output traceability, incomplete V&V coverage, unresolved deviations, risk-control gaps, transfer-readiness issues, and change-impact weaknesses. This supports QA, Regulatory, Engineering, Risk, Software, Usability, Manufacturing, and audit teams with faster, clearer, and more defensible pre-audit review.

-

This AI Transformation analyzes medical device labeling and promotional material — including Device Labels, Instructions for Use, Package Labeling, Marketing Claims Matrices, Indications-for-Use Forms, promotional websites and brochures, and patient/user training material — converting unstructured labeling and claims content into structured, evidence-based audit-readiness intelligence. It surfaces key signals such as unsupported or off-label claims, inconsistent indications-for-use language across documents, incomplete UDI or symbol information, unbalanced risk-benefit presentation, and training material misaligned with validated critical tasks. This supports Regulatory, Marketing, Legal, and Quality review, advertising-compliance screening, and inspection and notified body preparation with clearer, faster, and more traceable intelligence.

This AI Transformation analyzes medical device manufacturing documentation—Device Master Records, Device History Records, process validation files, equipment qualification records, environmental monitoring logs, supplier controls, acceptance activity records, and nonconformance/CAPA files—converting unstructured manufacturing evidence into structured, audit-ready intelligence. It surfaces key signals such as DMR specification completeness, DMR-to-DHR traceability, process validation adequacy, equipment calibration status, supplier qualification strength, unresolved nonconformances, and feedback-loop gaps. This supports internal audit-readiness review, QMSR and ISO 13485 preparation, and pre-inspection triage with clearer, faster, and more traceable manufacturing intelligence.

This AI Transformation analyzes medical device post-market documentation—Post-Market Surveillance Plans, complaint records, MDR decision records, CAPA and nonconformance files, field action and recall records, post-market risk reviews, trending and signal detection reports, service records, regulatory reporting logs, periodic safety reviews, marketed device change control, and labeling updates—converting unstructured post-market evidence into structured, audit-ready intelligence. It surfaces key signals such as complaint-to-MDR traceability, documented awareness dates and timeline discipline, CAPA effectiveness verification, field action health hazard evaluation, benefit-risk currency, and risk file feedback loops. This supports internal audit-readiness review, FDA and MDSAP inspection preparation, and closed-loop signal management with clearer, faster, and more traceable intelligence.

This AI Transformation analyzes medical device regulatory strategy and classification documentation — including Intended Use Statements, Indications for Use, Device Descriptions, Classification Memos, Regulatory Pathway Memos, Predicate Device Analyses, Substantial Equivalence Tables, and Regulatory Requirements Matrices — converting unstructured strategy documents into structured, evidence-based audit-readiness intelligence. It surfaces key signals such as scope creep between intended use and downstream claims, classification-to-pathway mismatches, predicate eligibility gaps, untested technological differences, and standards cited without supporting evidence. This supports Regulatory Affairs, Quality, and Clinical review, pre-submission readiness, and FDA and notified body audit preparation with clearer, faster, and more traceable intelligence.

This AI Transformation analyzes Risk Management Files — including Risk Management Plans, Hazard Analyses, FMEA/DFMEA/PFMEA records, Risk Control Matrices, Usability and Software Risk Analyses, Benefit-Risk Analyses, Risk Management Reports, and Post-Market Risk Update records — for medical device and biomedical product teams, converting unstructured risk documentation into structured, evidence-based audit-readiness intelligence. It surfaces key signals such as hazard-to-control traceability, unverified risk controls, unsupported residual-risk conclusions, thin usability or software risk coverage, and post-market feedback gaps. This supports internal audit preparation, notified body and MDSAP readiness, FDA inspection preparation, and cross-functional Risk Management, Quality, and Regulatory review with clearer, faster, and more traceable intelligence.

This AI Transformation analyzes medical device regulatory submission packages — including 510(k), De Novo, PMA, IDE, HDE, and Supplement/Amendment filings — converting unstructured, multi-section submission documentation into structured audit-readiness intelligence. It surfaces critical signals such as missing administrative certifications, unsupported substantial equivalence claims, broken traceability to underlying V&V and clinical evidence, internal consistency failures across submission sections, and cybersecurity documentation gaps. This supports Regulatory Affairs pre-submission reviews, Quality Assurance audit preparation, and filing defensibility assessments with faster, more traceable, and more consistent readiness intelligence — before a package faces FDA Refuse-to-Accept or Refuse-to-File screening.

This AI Transformation analyzes Verification and Validation (V&V) and clinical/regulatory evidence documentation for medical device manufacturers, biomedical product developers, and their quality, regulatory, and clinical teams — converting unstructured audit evidence packages into structured, evidence-based audit-readiness intelligence. It surfaces key signals such as requirements traceability gaps, unresolved test deviations, unsupported device claims, software and cybersecurity coverage weaknesses, and missing human subject protection records. This supports audit preparation, regulatory submission readiness, design control defensibility, and stakeholder review processes — including FDA inspections, ISO 13485 audits, notified body assessments, MDSAP audits, and IRB reviews — with clearer, faster, and more traceable intelligence.